|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
8,280,000 |
Market
Cap: |
1.69(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.3124 - $2.42 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Virios Therapeutics is a development-stage biotechnology company, which engages in the improvement of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. Co.'s primary candidate, IMC-1, is a proprietary, fixed dose combination of famciclovir and celecoxib. IMC-1 represents a combination, dual mechanism antiviral therapy designed to synergistically suppress herpes virus activation and replication, with the end goal of reducing viral mediated disease burden.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
40,335 |
49,835 |
Total Buy Value |
$0 |
$0 |
$51,237 |
$94,287 |
Total People Bought |
0 |
0 |
2 |
3 |
Total Buy Transactions |
0 |
0 |
2 |
4 |
Total Shares Sold |
0 |
0 |
0 |
1,800 |
Total Sell Value |
$0 |
$0 |
$0 |
$466 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
1 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pridgen William |
|
|
2023-08-21 |
4 |
B |
$1.30 |
$19,992 |
I/I |
15,335 |
52,045 |
0.01 |
-55% |
|
Duncan Gregory Scott |
CHIEF EXECUTIVE OFFICER |
|
2023-08-17 |
4 |
B |
$1.25 |
$31,245 |
D/D |
25,000 |
57,461 |
0.01 |
-52% |
|
Whitley Richard James |
|
|
2022-12-08 |
4 |
S |
$0.26 |
$466 |
D/D |
(1,800) |
700 |
|
-154% |
|
Walsh Angela |
SVP OF FINANCE |
|
2022-05-23 |
4 |
B |
$4.58 |
$9,150 |
I/I |
2,000 |
3,000 |
0.01 |
-91% |
|
Duncan Gregory Scott |
CHIEF EXECUTIVE OFFICER |
|
2022-05-23 |
4 |
B |
$4.52 |
$33,900 |
D/D |
7,500 |
32,461 |
0.01 |
-91% |
|
Pridgen William |
|
|
2022-05-18 |
4 |
B |
$4.50 |
$1,085 |
I/I |
241 |
36,710 |
0.01 |
-91% |
|
Whitley Richard James |
|
|
2022-05-18 |
4 |
B |
$4.53 |
$2,263 |
D/D |
500 |
2,500 |
0.01 |
-91% |
|
Pridgen William |
|
|
2022-05-17 |
4 |
B |
$4.38 |
$58,914 |
I/I |
13,450 |
36,469 |
0.01 |
-91% |
|
Pridgen William |
|
|
2022-03-29 |
4 |
B |
$4.94 |
$2,964 |
I/I |
600 |
23,019 |
0.01 |
43% |
|
Pridgen William |
|
|
2022-03-23 |
4 |
B |
$5.46 |
$12,002 |
I/I |
2,197 |
22,419 |
0.01 |
33% |
|
Pridgen William |
|
|
2022-01-27 |
4 |
B |
$5.98 |
$24,998 |
I/I |
4,180 |
18,722 |
0.01 |
-24% |
|
De La Rosa Abel |
|
|
2022-01-07 |
4 |
B |
$5.90 |
$23,584 |
D/D |
4,000 |
4,000 |
0.01 |
-19% |
|
Whitley Richard James |
|
|
2022-01-06 |
4 |
B |
$5.72 |
$10,296 |
D/D |
1,800 |
2,000 |
0.01 |
-20% |
|
Keefer David R |
|
|
2022-01-04 |
4 |
B |
$5.80 |
$28,975 |
D/D |
5,000 |
5,000 |
0.01 |
-38% |
|
Thomas John C |
|
|
2022-01-04 |
4 |
B |
$5.65 |
$5,650 |
D/D |
1,000 |
1,000 |
0.01 |
-38% |
|
Pridgen William |
|
|
2022-01-03 |
4 |
B |
$5.43 |
$12,034 |
I/I |
2,215 |
14,542 |
0.01 |
-38% |
|
Whitley Richard James |
|
|
2021-12-23 |
4 |
B |
$5.73 |
$1,145 |
D/D |
200 |
200 |
0.01 |
-30% |
|
Duncan Gregory Scott |
CHIEF EXECUTIVE OFFICER |
|
2021-12-21 |
4 |
B |
$5.52 |
$27,615 |
D/D |
5,000 |
24,961 |
0.01 |
-31% |
|
Pridgen William |
|
|
2021-12-21 |
4 |
B |
$5.66 |
$49,997 |
I/I |
8,827 |
12,327 |
0.01 |
-31% |
|
Pridgen William |
|
|
2021-07-07 |
4 |
AB |
$6.32 |
$5,951 |
D/D |
942 |
710,734 |
|
-9% |
|
Duncan Gregory Scott |
Chief Executive Officer |
|
2021-04-06 |
4 |
AB |
$6.36 |
$2,429 |
D/D |
382 |
19,961 |
|
-17% |
|
Pridgen William |
Director |
|
2021-01-29 |
4 |
B |
$7.47 |
$26,145 |
I/I |
3,500 |
3,500 |
2.1 |
-8% |
|
Walsh Angela |
VP of Finance |
|
2021-01-28 |
4 |
B |
$7.30 |
$7,300 |
I/I |
1,000 |
1,000 |
1.99 |
-14% |
|
Pridgen William |
Director |
|
2021-01-28 |
4 |
OE |
$7.80 |
$6,248 |
D/D |
801 |
727,993 |
|
- |
|
Keefer David R |
Director |
|
2021-01-28 |
4 |
OE |
$7.80 |
$12,496 |
I/I |
1,602 |
7,808 |
|
- |
|
30 Records found
|
|
Page 1 of 2 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|